AdaptHealth Corp.
NASDAQ:AHCO · NASDAQ Capital Market
+$0.01 today
Vol 2.32M · Avg 1.38M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$66.0M -169.7% | $94.8M +114.0% | -$678.9M -1028.3% | $73.1M -53.8% | $158.2M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $381.9M +4.5% | $365.3M -13.1% | $420.6M +19.8% | $351.2M +36.1% | $258.1M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $47.2M +47.2% | $32.0M +151.2% | -$62.6M -447.1% | $18.0M -19.4% | $22.4M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $21.9M +47.0% | $14.9M -33.8% | $22.5M +0.3% | $22.4M -11.6% | $25.3M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $66.6M +355.5% | -$26.1M -3.8% | -$25.1M +76.8% | -$108.0M +29.6% | -$153.3M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | $31.0M +218.2% | -$26.2M +9.2% | -$28.9M -13709.6% | -$209.0K +99.3% | -$29.7M | $592.6M | $1.3B | $626.2M |
| Inventory | -$11.5M +59.1% | -$28.1M -280.7% | $15.5M +346.5% | -$6.3M +57.8% | -$14.9M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $0 | $0 | $0 | $0 | $0 | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $47.1M +66.8% | $28.2M +339.6% | -$11.8M +88.4% | -$101.5M +6.6% | -$108.7M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $150.3M +146.9% | $60.9M -92.4% | $804.2M +4597.7% | $17.1M +149.0% | -$34.9M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $601.8M +11.1% | $541.8M +12.7% | $480.7M +28.6% | $373.9M +35.6% | $275.7M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$382.4M -24.9% | -$306.1M +9.3% | -$337.5M +13.8% | -$391.4M -92.5% | -$203.3M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | -$42.4M -344.4% | -$9.5M +51.6% | -$19.7M -3.5% | -$19.0M +98.8% | -$1.6B | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 | $0 +100.0% | -$128.0K +82.5% | -$731.0K +35.0% | -$1.1M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $121.6M +2187.0% | $5.3M | $0 | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$303.2M +2.3% | -$310.3M +13.2% | -$357.3M +13.1% | -$411.2M +77.5% | -$1.8B | $4.8B | $6.4B | $5.1B |
| Debt Repayment | -$268.5M -49.3% | -$179.9M -247.4% | -$51.8M -43.1% | -$36.2M -102.6% | $1.4B | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $1.2M | $0 | $0 | $0 -100.0% | $278.9M | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 +100.0% | -$29.3M -109.2% | -$14.0M | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$34.9M -83.0% | -$19.1M -66.2% | -$11.5M +27.7% | -$15.9M +79.0% | -$75.7M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$302.2M -51.9% | -$198.9M -115.0% | -$92.5M -40.1% | -$66.1M -104.1% | $1.6B | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 | $0 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$3.6M -111.1% | $32.6M +5.7% | $30.9M +129.9% | -$103.4M -308.1% | $49.7M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | $219.4M -7.0% | $235.8M +64.7% | $143.2M +915.7% | -$17.6M -124.3% | $72.4M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Establishment Labs Holdings Inc.
NASDAQ:ESTA
$2.52B
UFP Technologies, Inc.
NASDAQ:UFPT
$1.84B
Healthcare Services Group, Inc.
NASDAQ:HCSG
$1.56B
STAAR Surgical Company
NASDAQ:STAA
$1.43B
IRadimed Corporation
NASDAQ:IRMD
$1.18B
CureVac N.V.
CVAC
$1.05B
CONMED Corporation
NYSE:CNMD
$972.38M
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPH
$845.26M
InMode Ltd.
NASDAQ:INMD
$812.71M
Beta Bionics, Inc.
NASDAQ:BBNX
$605.82M
SEC Filings
Recent regulatory filings
No filings found.
Does AHCO generate free cash flow?
AdaptHealth Corp. (AHCO) generated $219.38M of free cash flow in fiscal 2025.
How much operating cash flow does AHCO produce?
Operating cash flow was $601.77M, before capital expenditures of $382.39M.
Explore More
Continue the stock analysis
Jump to another research area for this company.